【瑞银:升科伦博泰生物-B(06990.HK)ADC芦康沙妥珠单抗销售预测 上调目标价至452.8港元】智通财经APP获

智通财经
15 Jul
【瑞银:升科伦博泰生物-B(06990.HK)ADC芦康沙妥珠单抗销售预测 上调目标价至452.8港元】智通财经APP获悉,瑞银发布研报称,同时看好科伦博泰生物-B(06990.HK)SKB410、SKB571、SKB535等其他ADC资产的长期增长空间,将其目标价从320.1港元上调至452.8港元,维持“买入”评级。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10